Template:Zollinger-Ellison syndrome: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Zollinger-Ellison syndrome(patient information)|Patient | [[Zollinger-Ellison syndrome (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
| Line 29: | Line 29: | ||
! | ! | ||
[[Zollinger-Ellison syndrome historical perspective|Historical Perspective]] | [[Zollinger-Ellison syndrome historical perspective|Historical Perspective]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Zollinger-Ellison syndrome classification|Classification]] | |||
|- | |- | ||
! | ! | ||
| Line 40: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Zollinger-Ellison syndrome | [[Zollinger-Ellison syndrome causes|Causes]] | ||
|- | |- | ||
! | ! | ||
| Line 46: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Zollinger-Ellison syndrome | [[Zollinger-Ellison syndrome differential diagnosis|Differentiating Zollinger-Ellison syndrome from other Diseases]] | ||
|- | |- | ||
! | ! | ||
| Line 52: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Zollinger-Ellison syndrome | [[Zollinger-Ellison syndrome epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
| Line 58: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Zollinger-Ellison syndrome | [[Zollinger-Ellison syndrome risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
| Line 64: | Line 70: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Zollinger-Ellison syndrome | [[Zollinger-Ellison syndrome screening|Screening]] | ||
|- | |- | ||
! | ! | ||
| Line 70: | Line 76: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Zollinger-Ellison syndrome natural history|Natural History, Complications | [[Zollinger-Ellison syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
| Line 82: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Zollinger-Ellison syndrome history and symptoms|History | [[Zollinger-Ellison syndrome history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
| Line 94: | Line 100: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Zollinger-Ellison syndrome laboratory | [[Zollinger-Ellison syndrome laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
| Line 181: | Line 187: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |||
! | |||
Case Studies | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Zollinger-Ellison syndrome case study one|Case #1]] | |||
|- | |||
! | |||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " | ||
Revision as of 15:01, 17 September 2012
|
Zollinger-Ellison syndrome Microchapters |
|
Differentiating Zollinger-Ellison syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Zollinger-Ellison syndrome On the Web |
|
American Roentgen Ray Society Images of Zollinger-Ellison syndrome |
|
Risk calculators and risk factors for Zollinger-Ellison syndrome |